Literature DB >> 29467238

Ethanol Reversal of Oxycodone Tolerance in Dorsal Root Ganglia Neurons.

Joanna C Jacob1, Kensuke Sakakibara2, Ryan A Mischel2, Graeme Henderson2, William L Dewey2, Hamid I Akbarali1.   

Abstract

Oxycodone is a semisynthetic opioid compound that is widely prescribed, used, and abused today, and has a well-established role in shaping the current opioid epidemic. Previously, we have shown that tolerance develops to the antinociceptive and respiratory depressive effects of oxycodone in mice, and that a moderate dose of acute ethanol or a protein kinase C (PKC) inhibitor reversed that tolerance. To investigate further if tolerance was occurring through neuronal mechanisms, our aims for this study were to assess the effects of acute and prolonged oxycodone in isolated dorsal root ganglia (DRG) neurons and to determine if this tolerance was reversed by either ethanol or a PKC inhibitor. We found that an acute exposure to 3 μM oxycodone reduced neuronal excitability, as measured by increased threshold potentials and reduced action potential amplitude, without eliciting measurable changes in resting membrane potential. Exposure to 10 μM oxycodone for 18-24 hours prevented oxycodone's effect on neuronal excitability, indicative of tolerance development. The development of opioid tolerance was mitigated in DRG neurons from β-arrestin 2 knockout mice. Oxycodone tolerance was reversed in isolated DRG neurons by the acute application of either ethanol (20 mM) or the PKC inhibitor, bisindolylmaleimide XI hydrochloride (Bis XI), when a challenge of 3 µM oxycodone significantly reduced neuronal excitability following prolonged exposure. Through these studies, we concluded that oxycodone acutely reduced neuronal excitability, tolerance developed to this effect, and reversal of that tolerance occurred at the level of a single neuron, suggesting that reversal of oxycodone tolerance by either ethanol or Bis XI involves cellular mechanisms.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29467238      PMCID: PMC5878666          DOI: 10.1124/mol.117.110775

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  31 in total

1.  Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice.

Authors:  G A Patrick; W L Dewey; T C Spaulding; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

2.  The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA.

Authors:  Forrest L Smith; Ruby R Javed; Mark J Elzey; William L Dewey
Journal:  Brain Res       Date:  2003-09-19       Impact factor: 3.252

3.  Opioid-induced hypernociception is associated with hyperexcitability and altered tetrodotoxin-resistant Na+ channel function of dorsal root ganglia.

Authors:  Gracious R Ross; Aravind R Gade; William L Dewey; Hamid I Akbarali
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-21       Impact factor: 4.249

4.  Involvement of phospholipid signal transduction pathways in morphine tolerance in mice.

Authors:  F L Smith; A B Lohmann; W L Dewey
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

6.  Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice.

Authors:  Forrest L Smith; Bichoy H Gabra; Paul A Smith; Marcia C Redwood; William L Dewey
Journal:  Pain       Date:  2006-09-11       Impact factor: 6.961

7.  Acute ethanol administration rapidly increases phosphorylation of conventional protein kinase C in specific mammalian brain regions in vivo.

Authors:  Mary Beth Wilkie; Joyce Besheer; Stephen P Kelley; Sandeep Kumar; Todd K O'Buckley; A Leslie Morrow; Clyde W Hodge
Journal:  Alcohol Clin Exp Res       Date:  2007-05-20       Impact factor: 3.455

8.  Effect of Tamoxifen and Brain-Penetrant Protein Kinase C and c-Jun N-Terminal Kinase Inhibitors on Tolerance to Opioid-Induced Respiratory Depression in Mice.

Authors:  Sarah L Withey; Rob Hill; Abigail Lyndon; William L Dewey; Eamonn Kelly; Graeme Henderson
Journal:  J Pharmacol Exp Ther       Date:  2017-01-27       Impact factor: 4.030

9.  Morphine decreases enteric neuron excitability via inhibition of sodium channels.

Authors:  Tricia H Smith; John R Grider; William L Dewey; Hamid I Akbarali
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.

Authors:  Gregory Corder; Vivianne L Tawfik; Dong Wang; Elizabeth I Sypek; Sarah A Low; Jasmine R Dickinson; Chaudy Sotoudeh; J David Clark; Ben A Barres; Christopher J Bohlen; Grégory Scherrer
Journal:  Nat Med       Date:  2017-01-16       Impact factor: 53.440

View more
  1 in total

1.  Role of Acetaldehyde in Ethanol Reversal of Tolerance to Morphine-Induced Respiratory Depression in Mice.

Authors:  Rob Hill; Alexandra Conibear; William Dewey; Eamonn Kelly; Graeme Henderson
Journal:  Adv Drug Alcohol Res       Date:  2022-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.